Varex Imaging (NASDAQ:VREX) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Varex Imaging (NASDAQ:VREX) from a buy rating to a strong-buy rating in a report published on Saturday.

VREX has been the topic of a number of other reports. Oppenheimer lowered their target price on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday. Weiss Ratings restated a “sell (d)” rating on shares of Varex Imaging in a research report on Wednesday, October 8th. Finally, B. Riley reiterated a “buy” rating and issued a $16.00 target price on shares of Varex Imaging in a report on Wednesday. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $17.00.

Varex Imaging Price Performance

Shares of NASDAQ:VREX opened at $10.67 on Friday. The stock has a market cap of $444.94 million, a price-to-earnings ratio of -6.28 and a beta of 0.98. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.43 and a quick ratio of 1.82. Varex Imaging has a 12 month low of $6.76 and a 12 month high of $16.93. The stock’s 50 day moving average price is $11.78 and its 200 day moving average price is $9.87.

Varex Imaging (NASDAQ:VREX) last issued its quarterly earnings results on Tuesday, November 18th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.19. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%.The company had revenue of $228.90 million for the quarter, compared to analysts’ expectations of $219.26 million. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. Equities research analysts anticipate that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Varex Imaging

Several hedge funds have recently made changes to their positions in VREX. The Manufacturers Life Insurance Company grew its position in Varex Imaging by 10.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock worth $133,000 after purchasing an additional 1,442 shares in the last quarter. LSV Asset Management boosted its position in shares of Varex Imaging by 0.5% in the second quarter. LSV Asset Management now owns 328,610 shares of the company’s stock worth $2,849,000 after buying an additional 1,631 shares during the period. Comerica Bank grew its holdings in shares of Varex Imaging by 9.3% during the third quarter. Comerica Bank now owns 20,363 shares of the company’s stock valued at $253,000 after buying an additional 1,726 shares in the last quarter. BNP Paribas Financial Markets raised its position in Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after buying an additional 2,036 shares during the period. Finally, State of Alaska Department of Revenue purchased a new stake in Varex Imaging in the 3rd quarter worth about $27,000.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.